Predictors of Pain in Sickle Cell Disease

Recruiting N/A Interventional Study
Sickle Cell Disease Chronic Pain
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
15 – 40
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
70 (estimated)
Sponsor
Duke University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Sickle cell disease is a painful inherited disorder that affects approximately 100,000 people in the United States, and more than half of these individuals develop chronic or persistent pain that is often severe and disabling. The factors that predict whether an individual with sickle cell disease will develop severe, disabling pain are unclear. The goal of this project is to identify the factors …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
All participants must be between 15 and 40 years old and must be able to provide informed, written consent (for adults) or parental consent (for participants younger than 18 years). Inclusion Criteria: 1. Diagnosis of sickle cell disease (documentation of SS, SC, S beta + thalassemia, S beta + tha…
Contacts

Martha Kenney, MD

9196814877

martha.kenney@duke.edu

CONTACT

Nirmish Shah, MD

1919 668 5178

nirmish.shah@duke.edu

CONTACT